SALEMI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 189
EU - Europa 107
AS - Asia 60
AF - Africa 7
SA - Sud America 1
Totale 364
Nazione #
US - Stati Uniti d'America 188
IT - Italia 58
SG - Singapore 37
IE - Irlanda 12
SE - Svezia 10
IN - India 9
FI - Finlandia 8
CN - Cina 5
BG - Bulgaria 4
ID - Indonesia 4
TR - Turchia 4
DE - Germania 3
MA - Marocco 3
NL - Olanda 3
RU - Federazione Russa 3
EG - Egitto 2
GB - Regno Unito 2
PL - Polonia 2
TG - Togo 2
AR - Argentina 1
MX - Messico 1
RO - Romania 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 364
Città #
Singapore 29
Fairfield 23
Chandler 19
Rome 19
Ashburn 18
Woodbridge 14
Dublin 12
Seattle 12
Cambridge 11
Wilmington 10
Houston 9
Helsinki 7
Santa Clara 7
Milan 6
Ann Arbor 5
Princeton 5
Ankara 4
Boardman 4
Jakarta 4
Naples 4
Sofia 4
Capannori 3
Fasano 3
Lawrence 3
Moscow 3
Plano 3
Beijing 2
Boston 2
Calcio 2
Catania 2
Enschede 2
Giza 2
Lomé 2
Millbury 2
New York 2
Palermo 2
San Diego 2
San Paolo di Civitate 2
Warsaw 2
Andover 1
Colleferro 1
Council Bluffs 1
Federal 1
Hefei 1
Lappeenranta 1
Lucca 1
Newark 1
Norwalk 1
San Mateo 1
Solan 1
Tashkent 1
Wandsworth 1
Washington 1
Totale 281
Nome #
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 82
The still under-investigated role of cognitive deficits in PML diagnosis 69
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies 51
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register 37
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience 35
null 33
Prognostic indicators in pediatric clinically isolated syndrome 23
Evaluation of drivers of treatment switch in relapsing multiple sclerosis. A study from the Italian MS Registry 21
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study 18
Multiple Sclerosis Progression and Relapse Activity in Children 16
Late-onset multiple sclerosis. Disability trajectories in relapsing-remitting patients of the Italian MS Registry 12
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 5
COVID-19 severity in multiple sclerosis 3
null 3
Totale 408
Categoria #
all - tutte 1.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.666


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 0 6 6 7 6 4 3 1
2020/202113 1 2 0 0 0 1 0 1 1 0 1 6
2021/202253 6 8 2 1 9 2 1 3 5 3 7 6
2022/202365 11 11 1 6 8 3 2 6 8 0 3 6
2023/2024102 1 4 3 8 2 9 10 7 8 21 15 14
2024/202593 4 2 13 17 29 28 0 0 0 0 0 0
Totale 408